Front Barnett Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.43M | Hold |
9,152
| – | – | 0.17% | 53 |
|
|
2023
Q2 | $1.51M | Sell |
9,152
-15
| -0.2% | -$2.42K | 0.17% | 53 |
|
|
2023
Q1 | $1.42M | Sell |
9,167
-225
| -2% | -$36.3K | 0.17% | 55 |
|
|
2022
Q4 | $1.66M | Buy |
9,392
+140
| +2% | +$24.2K | 0.21% | 53 |
|
|
2022
Q3 | $1.51M | Sell |
9,252
-20
| -0.2% | -$3.38K | 0.2% | 51 |
|
|
2022
Q2 | $1.65M | Buy |
9,272
+43
| +0.5% | +$7.66K | 0.2% | 54 |
|
|
2022
Q1 | $1.64M | Sell |
9,229
-22
| -0.2% | -$3.74K | 0.16% | 56 |
|
|
2021
Q4 | $1.58M | Hold |
9,251
| – | – | 0.15% | 59 |
|
|
2021
Q3 | $1.49M | Sell |
9,251
-15
| -0.2% | -$2.56K | 0.15% | 62 |
|
|
2021
Q2 | $1.53M | Sell |
9,266
-60
| -0.6% | -$9.93K | 0.16% | 63 |
|
|
2021
Q1 | $1.53M | Sell |
9,326
-60
| -0.6% | -$9.71K | 0.17% | 56 |
|
|
2020
Q4 | $1.48M | Buy |
9,386
+15
| +0.2% | +$2.21K | 0.18% | 57 |
|
|
2020
Q3 | $1.4M | Sell |
9,371
-25
| -0.3% | -$3.7K | 0.19% | 55 |
|
|
2020
Q2 | $1.32M | Hold |
9,396
| – | – | 0.2% | 57 |
|
|
2020
Q1 | $1.23M | Sell |
9,396
-250
| -3% | -$35.5K | 0.24% | 56 |
|
|
2019
Q4 | $1.41M | Sell |
9,646
-2
| -0% | -$271 | 0.21% | 61 |
|
|
2019
Q3 | $1.25M | Sell |
9,648
-480
| -5% | -$63.2K | 0.21% | 60 |
|
|
2019
Q2 | $1.41M | Sell |
10,128
-196
| -2% | -$27.1K | 0.24% | 60 |
|
|
2019
Q1 | $1.44M | Buy |
10,324
+233
| +2% | +$31.2K | 0.23% | 60 |
|
|
2018
Q4 | $1.3M | Buy |
10,091
+63
| +0.6% | +$8.79K | 0.24% | 60 |
|
|
2018
Q3 | $1.39M | Sell |
10,028
-20
| -0.2% | -$2.66K | 0.21% | 61 |
|
|
2018
Q2 | $1.22M | Sell |
10,048
-30
| -0.3% | -$3.74K | 0.2% | 62 |
|
|
2018
Q1 | $1.29M | Hold |
10,078
| – | – | 0.22% | 62 |
|
|
2017
Q4 | $1.41M | Sell |
10,078
-703
| -7% | -$97.9K | 0.23% | 59 |
|
|
2017
Q3 | $1.4M | Hold |
10,781
| – | – | 0.25% | 59 |
|
|
2017
Q2 | $1.43M | Hold |
10,781
| – | – | 0.26% | 61 |
|
|
2017
Q1 | $1.34M | Hold |
10,781
| – | – | 0.25% | 60 |
|
|
2016
Q4 | $1.24M | Sell |
10,781
-737
| -6% | -$85.1K | 0.24% | 62 |
|
|
2016
Q3 | $1.36M | Sell |
11,518
-20
| -0.2% | -$2.43K | 0.26% | 61 |
|
|
2016
Q2 | $1.4M | Hold |
11,538
| – | – | 0.28% | 59 |
|
|
2016
Q1 | $1.25M | Buy |
11,538
+117
| +1% | +$12.1K | 0.25% | 62 |
|
|
2015
Q4 | $1.17M | Hold |
11,421
| – | – | 0.23% | 66 |
|
|
2015
Q3 | $1.07M | Hold |
11,421
| – | – | 0.22% | 66 |
|
|
2015
Q2 | $1.11M | Hold |
11,421
| – | – | 0.21% | 62 |
|
|
2015
Q1 | $1.15M | Buy |
11,421
+600
| +6% | +$61K | 0.21% | 61 |
|
|
2014
Q4 | $1.13M | Hold |
10,821
| – | – | 0.21% | 59 |
|
|
2014
Q3 | $1.15M | Sell |
10,821
-200
| -2% | -$20.7K | 0.22% | 60 |
|
|
2014
Q2 | $1.15M | Sell |
11,021
-506
| -4% | -$51.1K | 0.21% | 60 |
|
|
2014
Q1 | $1.13M | Buy |
11,527
+155
| +1% | +$14.4K | 0.22% | 59 |
|
|
2013
Q4 | $1.04M | Sell |
11,372
-51
| -0.4% | -$4.7K | 0.2% | 60 |
|
|
2013
Q3 | $990K | Buy |
11,423
+50
| +0.4% | +$4.49K | 0.21% | 61 |
|
|
2013
Q2 | $976K | Buy |
+11,373
| New | +$965K | 0.22% | 59 |
|
Other funds holding JNJ
Front Barnett Associates's JNJ Position: Q3 2023 in Review
Front Barnett Associates held its Johnson & Johnson (JNJ) position steady in Q3 2023 at 9,152 shares worth $1.43M. The position accounts for 0.17% of the portfolio, ranked #53.
Front Barnett Associates first reported a position in JNJ in Q2 2013 and has held it in 42 quarters since. The position peaked at $1.66M in Q4 2022. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.
- Front Barnett Associates held 9,152 shares of Johnson & Johnson worth $1.43M as of Q3 2023.
- Front Barnett Associates left its Johnson & Johnson share count unchanged in Q3 2023.
- Johnson & Johnson made up 0.17% of Front Barnett Associates's portfolio in Q3 2023, its #53 holding.
- Front Barnett Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 42 quarters since.
- Front Barnett Associates's Johnson & Johnson position peaked at $1.66M in Q4 2022.
- 3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.
Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.